# A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer

> **NCT01268059** · PHASE1,PHASE2 · TERMINATED · sponsor: **MedImmune LLC** · enrollment: 99 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Paclitaxel
- **DRUG:** MEDI-575

## Key facts

- **NCT ID:** NCT01268059
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-12-16
- **Primary completion:** 2013-09-11
- **Final completion:** 2013-09-11
- **Target enrollment:** 99 (ACTUAL)
- **Why stopped:** In conjunction with the overall risk-benefit assessment, study was terminated prematurely due to safety concerns.
- **Last updated:** 2020-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01268059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01268059, "A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01268059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*